Switch theme
Sign up to access all valuation multiples
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.
1983
5.3K+
LTM Revenue $1.5B
LTM EBITDA $392M
$10.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cochlear has a last 12-month revenue of $1.5B and a last 12-month EBITDA of $392M.
In the most recent fiscal year, Cochlear achieved revenue of $1.4B and an EBITDA of $366M.
Cochlear expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cochlear valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.4B | XXX | XXX | XXX |
| Gross Profit | $782M | $916M | XXX | XXX | XXX |
| Gross Margin | 64% | 65% | XXX | XXX | XXX |
| EBITDA | $308M | $366M | XXX | XXX | XXX |
| EBITDA Margin | 25% | 26% | XXX | XXX | XXX |
| Net Profit | $183M | $190M | XXX | XXX | XXX |
| Net Margin | 15% | 13% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 17, 2025, Cochlear's stock price is AUD 262 (or $166).
Cochlear has current market cap of AUD 17.2B (or $10.8B), and EV of AUD 17.0B (or $10.8B).
See Cochlear trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10.8B | $10.8B | XXX | XXX | XXX | XXX | $3.90 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 17, 2025, Cochlear has market cap of $10.8B and EV of $10.8B.
Cochlear's trades at 7.2x LTM EV/Revenue multiple, and 27.4x LTM EBITDA.
Analysts estimate Cochlear's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Cochlear and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $10.8B | XXX | XXX | XXX |
| EV/Revenue | 7.3x | XXX | XXX | XXX |
| EV/EBITDA | 28.1x | XXX | XXX | XXX |
| P/E | 44.7x | XXX | XXX | XXX |
| P/E/Growth | 3.3x | XXX | XXX | XXX |
| EV/FCF | 52.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCochlear's NTM/LTM revenue growth is 9%
Cochlear's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Cochlear's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Cochlear's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Cochlear and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 35% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 31% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 56% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cochlear acquired XXX companies to date.
Last acquisition by Cochlear was XXXXXXXX, XXXXX XXXXX XXXXXX . Cochlear acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Cochlear founded? | Cochlear was founded in 1983. |
| Where is Cochlear headquartered? | Cochlear is headquartered in Australia. |
| How many employees does Cochlear have? | As of today, Cochlear has 5.3K+ employees. |
| Who is the CEO of Cochlear? | Cochlear's CEO is Mr. Dig Howitt. |
| Is Cochlear publicy listed? | Yes, Cochlear is a public company listed on ASX. |
| What is the stock symbol of Cochlear? | Cochlear trades under COH ticker. |
| When did Cochlear go public? | Cochlear went public in 1995. |
| Who are competitors of Cochlear? | Similar companies to Cochlear include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Cochlear? | Cochlear's current market cap is $10.8B |
| What is the current revenue of Cochlear? | Cochlear's last 12-month revenue is $1.5B. |
| What is the current EBITDA of Cochlear? | Cochlear's last 12-month EBITDA is $392M. |
| What is the current EV/Revenue multiple of Cochlear? | Current revenue multiple of Cochlear is 7.2x. |
| What is the current EV/EBITDA multiple of Cochlear? | Current EBITDA multiple of Cochlear is 27.4x. |
| What is the current revenue growth of Cochlear? | Cochlear revenue growth between 2023 and 2024 was 15%. |
| Is Cochlear profitable? | Yes, Cochlear is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
